When Sridharan Gururangan, FRCP, joined the University of Florida College of Medicine’s department of neurosurgery in 2016, he had a big goal for the university: become a member of the Pediatric Brain Tumor Consortium.
On July 16, 2020, Gururangan achieved that objective when UF was named one of four new PBTC member institutions along with the Dana-Farber Cancer Institute in Boston; Nationwide Children’s Hospital in Columbus, Ohio; and the Hospital for Sick Children in Toronto.
The achievement allows UF pediatric brain tumor researchers the ability to collaborate and rapidly enroll patients in clinical trials and offers patients access to some of the world’s most leading-edge research technology and expertise.
“This is a huge win for the University of Florida,” said Gururangan, who will serve as the principal investigator for the UF consortium site. “This puts UF on the map in terms of our brain tumor expertise.”Learn more about UF Named New Member of Prestigious Pediatric Brain Tumor Consortium.